CGONCG Oncology, Inc.
$61.68+47% 1Y
$61.68
$37.3752 weeks$80.66
Is the price fair?
What CGON's price assumes
CG Oncology, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 878× revenue.
878
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 5.31
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 713
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 5.31
- EV / EBIToperating margin −4056%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 713
- Market capitalisation88.6 million shares, counted Aug 5, 2026
- $5.47B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks
Biotechnology
The closest names by size in the same industry